Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has exercised ...
The winter conditions that Afghanistan is experiencing have turned life-threatening. Instead, relief from drought could have been what this country ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback